Chmn Sullivan Gifts 2,000 Of Mesa Laboratories Inc [MLAB]

Sullivan John James Chairman of the Board of Mesa Laboratories Inc [MLAB] filed a Form 4 on December 5, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/2/25TransactionGiftShares2,000Price$0.00ValueN/AEnding Holdings: 70,062 (25,282 - Direct, 44,780 - Indirect) For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Mesa Laboratories Inc. to Announce Third Quarter Results

Mesa Laboratories, Inc. (NASDAQ:MLAB) will release its third quarter fiscal 2026 financial results on February 3, 2026, at 8:00 A.M. Eastern Time. The results will be accessible on the company's website. This announcement was originally published via GlobeNewswire and is intended for informational purposes only.

Mesa Laboratories to Join Jefferies London Healthcare Conference

Mesa Laboratories Inc. will participate in a fireside chat at the Jefferies London Healthcare Conference on November 20, 2025, at 12:00 p.m. GMT. President and CEO Gary Owens and CFO John Sakys will represent the company, and the event will be accessible via live webcast.

Mesa Laboratories Inc reports results for the quarter ended September 30 - Earnings Summary

Mesa Laboratories Inc reported adjusted earnings of 45 cents per share for the quarter ended September 30, down from 80 cents a year ago. Revenue increased 5% to $60.74 million, slightly above analyst expectations. The company’s net income was $2.48 million. Despite a 10.7% rise in shares this quarter, they have fallen 43.7% year-to-date. Analysts maintain a "buy" rating, with a median 12-month price target of $88.50, 15.4% above the last closing price of $74.87.

Mesa Laboratories | 10-Q: FY2026 Q2 Revenue Beats Estimate at USD 60.74 M